|
ZNF830 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.23061585763662E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
8.108000E-01 |
| Stage1-vs-Stage3 |
1.009770E-01 |
| Stage1-vs-Stage4 |
1.553980E-02 |
| Stage2-vs-Stage3 |
3.934600E-01 |
| Stage2-vs-Stage4 |
1.789020E-01 |
| Stage3-vs-Stage4 |
4.478600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.36950023438476E-10 |
| Normal-vs-Asian |
1.67839997455843E-09 |
| Caucasian-vs-AfricanAmerican |
9.067400E-01 |
| Caucasian-vs-Asian |
2.260400E-02 |
| AfricanAmerican-vs-Asian |
1.280830E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.743000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.51290000000226E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.134400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.482350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.418000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.700800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.434400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.344800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.390170E-02 |
| Classical-VS-Follicular |
8.639000E-03 |
| Classical-VS-Other |
7.663200E-01 |
| Classical-VS-Normal |
5.73985303731206E-14 |
| Tall-VS-Follicular |
6.786800E-01 |
| Tall-VS-Other |
6.486000E-01 |
| Tall-VS-Normal |
2.88657986402541E-15 |
| Follicular-VS-Other |
6.717600E-01 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
3.816100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.11022302462516E-16 |
| N0-vs-N1 |
2.125600E-01 |
|
|
